Vista Pharma Financials

BSE: 524711

₹6.28

₹0.04 (0.64%)

As on 04-Sep-2026IST

Market cap

₹39 Cr

Revenue (TTM)

₹4 Cr

P/E Ratio

--

P/B Ratio

1.1

Div. Yield

0 %

Annual
Quarterly

Income Statement (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Operating Revenue	3.88	10.07	10.29	1.00	0.39	1.27
Total Income	4.24	10.52	10.62	1.40	0.56	1.46
Total Expenditure	18.23	14.10	13.84	5.32	1.66	3.00
EBITDA	-14.35	-4.03	-3.55	-4.32	-1.27	-1.73
Depreciation	0.76	0.74	0.72	0.62	0.62	0.73
EBIT	-15.11	-4.76	-4.27	-4.93	-1.88	-2.46
Interest	1.24	0.97	1.24	1.34	0.90	1.55
Other Income	0.36	0.44	0.33	0.40	0.17	0.20
Exceptional Items	--	--	--	--	--	--
Profit before Tax	-16.00	-5.29	-5.18	-5.88	-2.62	-3.81
Provision for Tax	-4.24	-0.64	-0.67	-0.21	-1.73	-1.80
Profit after Tax	-11.76	-4.65	-4.51	-5.66	-0.89	-2.01

Liabilities (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Shareholder's Funds	36.44	45.42	40.46	36.71	35.45	32.85
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	2.00	-1.87	-0.28	2.60	4.02	10.51
Current Liabilities	16.65	12.37	14.49	14.08	12.64	9.25
Total Liabilities	55.08	60.29	57.98	56.03	55.59	52.61

Assets (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Non-Current Assets	37.37	41.16	41.37	31.20	28.55	37.37
Current Assets	15.36	14.76	13.30	22.19	23.56	15.24
Total Assets	55.08	60.29	57.98	56.03	55.59	52.61
Total Debt*	--	7.40	7.96	9.96	12.55	10.71
Net Current Assets	-1.28	2.39	-1.19	8.11	10.92	5.99
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Cash From Operating Activities	--	-6.98	-4.91	-1.71	-0.99	-6.75
Cash Flow from Investing Activities	--	-0.44	-0.79	-1.27	-0.01	-0.30
Cash from Financing Activities	--	8.06	5.59	3.11	0.94	6.96
Net Cash Inflow / Outflow	--	0.64	-0.11	0.13	-0.07	-0.09

Financials Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Adjusted EPS (₹)	-1.91	-0.76	-0.96	-1.51	-0.24	-0.55
Cash EPS (₹)	-1.91	-0.64	-0.80	-1.34	-0.07	-0.35
Adjusted Book Value (₹)	5.76	7.38	7.56	8.13	9.64	8.93
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	-1.13	-1.04	-0.46	-0.27	-1.83
Free Cash Flow per Share (₹)	--	-1.19	-1.33	-1.34	-0.05	-1.87

Profitability Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
ROCE (%)	--	-8.54	-8.28	-9.58	-3.75	-5.10
ROE (%)	-29.00	-11.47	-13.63	-17.16	-2.60	-6.43
ROA (%)	-20.38	-8.41	-8.35	-10.73	-1.70	-3.89
EBIT Margin (%)	-389.43	-47.28	-41.49	-491.62	-477.32	-194.05
Net Margin (%)	-277.62	-44.21	-42.48	-403.54	-158.59	-137.45
Cash Profit Margin (%)	0.00	-38.82	-36.86	-502.58	-69.03	-101.15

Growth Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Revenue Growth (%)	-60.40	-2.07	924.99	154.36	-68.84	-94.44
EBIT Growth (%)	-196.62	-11.59	13.49	-161.98	23.35	60.00
Net Profit Growth (%)	-131.35	-3.03	20.31	-537.18	55.76	45.37
EPS Growth (%)	-131.37	21.05	36.55	-524.27	55.76	54.92
Book Value Growth (%)	--	27.38	16.69	-13.83	7.94	10.81

Valuation Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Price / Earnings	-3.29	--	--	--	--	--
Price / Book Value	1.09	1.46	1.41	1.03	0.96	1.01
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-3.47	-20.30	-18.08	-10.51	-42.12	-28.56
Close Price (₹)	7.16	10.74	10.66	8.36	9.22	9.04
High Price (₹)	11.69	16.59	19.70	14.41	17.57	16.10
Low Price (₹)	5.71	9.10	7.65	6.51	7.40	4.79
Market Cap (₹ Cr)	38.65	66.11	50.28	31.40	33.92	33.26

Solvency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debt to Equity	0.05	0.16	0.22	0.33	0.35	0.33
Short term debt to equity ratio	--	0.11	0.12	0.13	0.14	0.06
Current Ratio	0.92	1.19	0.92	1.58	1.86	1.65
Quick Ratio	0.26	0.53	0.45	1.03	1.13	0.60
Interest Coverage	-11.86	-4.47	-3.17	-3.38	-1.91	-1.46

Operating Efficiency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debtors to sales (%)	8.17	33.68	40.71	1,120.94	2,651.80	171.29
Asset Turnover	0.07	0.18	0.19	0.02	0.01	0.02
Receivable days	--	137.33	273.88	3,948.36	5,842.77	1,794.10
Inventory Days	--	271.84	256.57	3,091.84	8,791.54	2,790.39
Payable days	--	284.27	312.19	849.73	5,212.95	2,566.27
Cash Conversion Cycle	--	124.89	218.25	6,190.47	9,421.37	2,018.22

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.